Proteinase 3 PR1 peptide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Proteinase 3 PR1 peptide, covering 2014-04-30 to 2014-04-30. Get the full timeline:
Most recent: Clinical Trial Update: Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R) [Phase 2]